- Category
- Client Alerts
- Date
- April 07, 2016
- Title
-
Federal Circuit Preserves Plaintiff’s Choice of Forum in Hatch-Waxman Cases
This alert examines the impact of the Federal Circuit’s decision in Acorda Therapeutics Inc. v. Mylan Pharmaceuticals Inc., which held that future sales by a generic defendant of the patented product at issue is a basis for specific jurisdiction over the defendant. In doing so, the Court preserved the ability of a Hatch-Waxman plaintiff to choose the litigation forum.
Related People
-
-
Shannon H. Hedvat
-
- Special Counsel
- Co-author
- New York
- vcard
-
